News

Researchers found that lenacapavir reduced almost 100% reduction new HIV infections among participants who received it as a ...
After the virologic failure of cabotegravir/rilpivirine and despite dual-class resistance mutations, Canadian doctors have ...
The World Health Organization on Monday recommended Gilead's lenacapavir, a twice-yearly injection, as a tool to prevent HIV ...
Newborns exposed to HIV during pregnancy or birth should receive preventive antiretroviral medication immediately after ...
Artificial intelligence chatbots could help with the introduction of a twice-yearly shot that can help prevent HIV, experts ...
The World Health Organization is now recommending that countries include an HIV drug newly approved for prevention, ...
ViiV Healthcare, the HIV-focused joint venture majority owned by GSK , said on Monday it has expanded its licensing deal with ...
State attorneys general and federal prosecutors alleged Gilead Sciences illegally bankrolled lavish events for prescribers.
A landmark breakthrough in HIV prevention — a scientific feat decades in the making — received final approval from the Food ...
SA has accepted an offer of just over R520-million from the Global Fund to Fight Aids, TB and Malaria to buy the twice-a-year ...